(Q31125369)

29 June 2017

0 references

1 reference

title

Magnesium sulphate for preventing preterm birth in threatened preterm labour. (English)

1 reference

29 June 2017

0 references

1 reference

C A Crowther

1

1 reference

29 June 2017

J E Hiller

series ordinal

2

1 reference

29 June 2017

L W Doyle

series ordinal

3

1 reference

29 June 2017

publication date

1 January 2002

1 reference

Cochrane Database of Systematic Reviews

29 June 2017

published in

1 reference

29 June 2017

issue

4

1 reference

29 June 2017

page(s)

CD001060

1 reference

Evaluation of maternal fluid dynamics during tocolytic therapy with ritodrine hydrochloride and magnesium sulfate

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

A comparison of ritodrine, terbutaline, and magnesium sulfate for the suppression of preterm labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Randomized investigation of magnesium sulfate for prevention of preterm birth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Randomized comparison of intravenous nitroglycerin and magnesium sulfate for treatment of preterm labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Prevention of preterm delivery: nifedipine or magnesium sulfate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Magnesium sulfate and ritodrine hydrochloride: a randomized comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

The use of ritodrine and magnesium sulfate in the arrest of premature labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Is tocolytic magnesium sulphate associated with increased total paediatric mortality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Umbilical cord serum ionized magnesium level and total pediatric mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Association between maternal serum ionized magnesium levels at delivery and neonatal intraventricular hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Tocolytic magnesium sulfate: are the epidemiologic data reassuring?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

If tocolytic magnesium sulfate is associated with excess total pediatric mortality, what is its impact?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Efficacy and side effects of magnesium sulfate and ritodrine as tocolytic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Adjunctive use of magnesium sulfate with ritodrine for preterm labor tocolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Adjunctive magnesium sulfate infusion does not alter metabolic changes associated with ritodrine tocolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Tocolytic magnesium sulfate toxicity and unexpected neonatal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

An overview of the possible relationship between antenatal pharmacologic magnesium and cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Lack of effect of antenatal indomethacin on fetal cerebral blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Adverse and beneficial effects of tocolytic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Perinatal death and tocolytic magnesium sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Influence of maternal magnesium sulphate and ritodrine treatment on cerebral blood flow velocity of the preterm newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

Functional abilities at age 4 years of children born before 29 weeks of gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001060

10.1002/14651858.CD001060

21 January 2018

Identifiers

DOI

1 reference

29 June 2017

1 reference